top of page
.png)
Search
Beyond Rituximab: Obinutuzumab Redefines Treatment in Resistant Membranous Nephropathy
Written by Priyadarshini John, DM Primary membranous nephropathy (MN) is a prototypical autoimmune glomerular disease and one of the most common causes of nephrotic syndrome in adults. The discovery of circulating autoantibodies against podocyte antigens, most notably the phospholipase A2 receptor (PLA2R) has transformed the understanding of its pathogenesis, firmly establishing MN as a B-cell–mediated disorder. This paradigm shift has led to the emergence of targeted immunot
Priyadarshini John DM
9 minutes ago7 min read
The Unasked Questions of Sexual Health in Nephrology Clinics
Reproductive & sexual health in CKD is often overlooked in nephrology. Explore risks, hormonal disruption, and the critical communication gap in nephrology care.
Priti Meena, MD
2 days ago7 min read
Can Dulaglutide Modify the Proteomic Signature of CKD Progression? Impacts Beyond Glycemic Control
Dulaglutide may slow CKD progression by modulating inflammatory and fibrotic pathways beyond glucose control.
sophiaambruso
6 days ago3 min read
bottom of page